SHR0687
SHR0687 is a selective tetrapeptide kappa opioid receptor (KOR) agonist with an EC50 of 0.53 pM. SHR0687 displays high potency and selectivity over MOR and DOR, with negligible blood-brain barrier penetration. SHR0687 activates KOR specifically, leading to potential modulation of neurological pathways without significant central nervous system effects. SHR0687 can be used for the research of pain.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2168573-03-1
- 分子式: C39H60N8O5
- 分子量:720.94
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Opioid Receptor アイソフォーム固有の製品をすべて表示
More
生物活性
|
κ Opioid Receptor/KOR 0.53 pM (EC50) |
μ Opioid Receptor/MOR >50000 nM (EC50) |
δ Opioid Receptor/DOR >50000 nM (EC50) |
SHR0687 (Human embryonic kidney cells (HEK293)) does not inhibit hERG channels[1].
SHR0687 (Human liver microsomes) does not significantly inhibit major CYP isoforms, including CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
SHR0687 (1 mg/kg; Intravenous (IV); administration) shows minimal BBB penetration in Sprague Dawley rats (SD)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague Dawley rats (SD) (150-180 g) were subcutaneously injected with 1% carrageenan (100 μL)[1]
-
Dosage:0.03 mg/kg, 0.1 mg/kg, 0.3 mg/kg
-
Administration:i.v.;30 minutes before detection
-
Result:A dose-dependent reduction in pain was observed.
化学情報
-
CAS 番号 2168573-03-1
-
分子量 720.94
-
分子式 C39H60N8O5
-
SMILES
C[C@H](C1=CC=CC=C1)CNCC(N[C@H](CC2=CC=CC=C2)C(N[C@H](CC(C)C)C(N[C@H](CCCCN)C(N3CCC(CC3)NC(NC)=O)=O)=O)=O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)